Episode Details
Back to EpisodesE126: Risk Signals, JAKs, and SELECTIVE-ity
Episode 127
Published 7 months, 3 weeks ago
Description
Covering an interesting but ultimately disappointing post hoc study of multiple upadacitinib trials in RA. Initially some hope for clarity in the "Do JAKs cause all the badness?" questions, but ultimately landing me about where I have been since ORAL-SURVEILLANCE was published
Paper: https://www.sciencedirect.com/science/article/pii/S0003496724423091